Amalgamated Bank Kezar Life Sciences, Inc. Transaction History

Amalgamated Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$0.8 - $1.05 $3,909 - $5,131	-4,887 Reduced 75.0%	1,629 $1,000
Q4 2023 Feb 06, 2024	SELL	$0.72 - $1.15 $349 - $557	-485 Reduced 6.93%	6,516 $6,000
Q3 2023 Nov 08, 2023	BUY	$1.08 - $2.54 $1,955 - $4,599	1,811 Added 34.89%	7,001 $8,000
Q1 2023 May 02, 2023	SELL	$3.13 - $7.31 $4,022 - $9,393	-1,285 Reduced 19.85%	5,190 $16,000
Q3 2022 Nov 09, 2022	BUY	$7.99 - $10.75 $4,514 - $6,073	565 Added 9.56%	6,475 $56,000
Q2 2022 Aug 15, 2022	BUY	$4.58 - $17.13 $7,776 - $29,086	1,698 Added 40.31%	5,910 $49,000
Q1 2022 Jun 30, 2022	BUY	$12.3 - $18.33 $51,807 - $77,205	4,212 New	4,212 $70,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $430M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.